Cargando…

Natural products remodel cancer-associated fibroblasts in desmoplastic tumors

Desmoplastic tumors have an abundance of stromal cells and the extracellular matrix which usually result in therapeutic resistance. Current treatment prescriptions for desmoplastic tumors are usually not sufficient to eliminate the malignancy. Recently, through modulating cancer-associated fibroblas...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Rujing, Huang, Leaf, Hu, Kaili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714988/
https://www.ncbi.nlm.nih.gov/pubmed/33304782
http://dx.doi.org/10.1016/j.apsb.2020.04.005
_version_ 1783618849260699648
author Chen, Rujing
Huang, Leaf
Hu, Kaili
author_facet Chen, Rujing
Huang, Leaf
Hu, Kaili
author_sort Chen, Rujing
collection PubMed
description Desmoplastic tumors have an abundance of stromal cells and the extracellular matrix which usually result in therapeutic resistance. Current treatment prescriptions for desmoplastic tumors are usually not sufficient to eliminate the malignancy. Recently, through modulating cancer-associated fibroblasts (CAFs) which are the most abundant cell type among all stromal cells, natural products have improved chemotherapies and the delivery of nanomedicines to the tumor cells, showing promising ability to improve treatment effects on desmoplastic tumors. In this review, we discussed the latest advances in inhibiting desmoplastic tumors by modeling CAFs using natural products, highlighting the potential therapeutic abilities of natural products in targeting CAFs for cancer treatment.
format Online
Article
Text
id pubmed-7714988
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-77149882020-12-09 Natural products remodel cancer-associated fibroblasts in desmoplastic tumors Chen, Rujing Huang, Leaf Hu, Kaili Acta Pharm Sin B Review Desmoplastic tumors have an abundance of stromal cells and the extracellular matrix which usually result in therapeutic resistance. Current treatment prescriptions for desmoplastic tumors are usually not sufficient to eliminate the malignancy. Recently, through modulating cancer-associated fibroblasts (CAFs) which are the most abundant cell type among all stromal cells, natural products have improved chemotherapies and the delivery of nanomedicines to the tumor cells, showing promising ability to improve treatment effects on desmoplastic tumors. In this review, we discussed the latest advances in inhibiting desmoplastic tumors by modeling CAFs using natural products, highlighting the potential therapeutic abilities of natural products in targeting CAFs for cancer treatment. Elsevier 2020-11 2020-04-19 /pmc/articles/PMC7714988/ /pubmed/33304782 http://dx.doi.org/10.1016/j.apsb.2020.04.005 Text en © 2020 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review
Chen, Rujing
Huang, Leaf
Hu, Kaili
Natural products remodel cancer-associated fibroblasts in desmoplastic tumors
title Natural products remodel cancer-associated fibroblasts in desmoplastic tumors
title_full Natural products remodel cancer-associated fibroblasts in desmoplastic tumors
title_fullStr Natural products remodel cancer-associated fibroblasts in desmoplastic tumors
title_full_unstemmed Natural products remodel cancer-associated fibroblasts in desmoplastic tumors
title_short Natural products remodel cancer-associated fibroblasts in desmoplastic tumors
title_sort natural products remodel cancer-associated fibroblasts in desmoplastic tumors
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714988/
https://www.ncbi.nlm.nih.gov/pubmed/33304782
http://dx.doi.org/10.1016/j.apsb.2020.04.005
work_keys_str_mv AT chenrujing naturalproductsremodelcancerassociatedfibroblastsindesmoplastictumors
AT huangleaf naturalproductsremodelcancerassociatedfibroblastsindesmoplastictumors
AT hukaili naturalproductsremodelcancerassociatedfibroblastsindesmoplastictumors